| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/RLI.0B013E3181461D21 |
| P698 | PubMed publication ID | 18007156 |
| P50 | author | Ghee Young Kwon | Q86913049 |
| P2093 | author name string | Byung Kwan Park | |
| Hyun Moo Lee | |||
| Chan Kyo Kim | |||
| P433 | issue | 12 | |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 842-847 | |
| P577 | publication date | 2007-12-01 | |
| P1433 | published in | Investigative Radiology | Q15734073 |
| P1476 | title | Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results | |
| P478 | volume | 42 |
| Q38211143 | 1.5-T multiparametric MRI using PI-RADS: a region by region analysis to localize the index-tumor of prostate cancer in patients undergoing prostatectomy |
| Q37846042 | A Clinically Relevant Approach to Imaging Prostate Cancer: Review |
| Q38052458 | Advances in oncologic imaging: update on 5 common cancers |
| Q37127345 | Advances in prostate cancer imaging techniques and strategies |
| Q41517377 | Biexponential Apparent Diffusion Coefficients Values in the Prostate: Comparison among Normal Tissue, Prostate Cancer, Benign Prostatic Hyperplasia and Prostatitis |
| Q92173303 | Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer |
| Q33590993 | Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology |
| Q53042434 | Comparison of re-biopsy with preceded MRI and re-biopsy without preceded MRI in patients with previous negative biopsy and persistently high PSA. |
| Q41331723 | Comparison of stretched-Exponential and monoexponential model diffusion-Weighted imaging in prostate cancer and normal tissues |
| Q55365478 | Correlation of apparent diffusion coefficient ratio on 3.0 T MRI with prostate cancer Gleason score. |
| Q34256443 | DW-MRI of the urogenital tract: applications in oncology. |
| Q84866007 | Diagnostic accuracy of ultra-high-b-value 3.0-T diffusion-weighted MR imaging for detection of prostate cancer |
| Q53098704 | Diagnostic value of ADC in patients with prostate cancer: influence of the choice of b values |
| Q38411032 | Diagnostic value of integrated PET/MRI for detection and localization of prostate cancer: Comparative study of multiparametric MRI and PET/CT. |
| Q42418722 | Diffusion tensor imaging of normal prostate at 3 T: effect of number of diffusion-encoding directions on quantitation and image quality |
| Q84131769 | Diffusion tensor imaging of prostate at 3.0 Tesla |
| Q42112215 | Diffusion-Weighted Magnetic Resonance Imaging for the Evaluation of Prostate Cancer: Optimal B Value at 3T |
| Q35663658 | Diffusion-weighted MR imaging in gynecologic cancers |
| Q34995967 | Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness |
| Q84595503 | Diffusion-weighted imaging of local recurrent prostate cancer after radiation therapy: comparison with 22-core three-dimensional prostate mapping biopsy |
| Q33464875 | Diffusion-weighted imaging with apparent diffusion coefficient mapping and spectroscopy in prostate cancer |
| Q53117487 | Diffusion-weighted magnetic resonance imaging in prostate cancer patients on active surveillance one year after diagnosis and before repeat biopsy |
| Q34742733 | Diffusion‐weighted MRI and its role in prostate cancer |
| Q24620926 | ESUR prostate MR guidelines 2012 |
| Q45396642 | Effect of intravenous gadolinium-DTPA on diffusion-weighted imaging for prostate lesions and normal tissue at 3.0-Tesla magnetic resonance imaging |
| Q37853283 | Feasibility of a Pneumatically Actuated MR-compatible Robot for Transrectal Prostate Biopsy Guidance |
| Q43095308 | Feasibility of multiparametric prostate magnetic resonance imaging in the detection of cancer distribution: histopathological correlation with prostatectomy specimens. |
| Q27009471 | Functional MRI in prostate cancer detection |
| Q38598175 | Geometric distortion correction in prostate diffusion-weighted MRI and its effect on quantitative apparent diffusion coefficient analysis |
| Q51047245 | High and ultra-high b-value diffusion-weighted imaging in prostate cancer: a quantitative analysis |
| Q37875083 | Imaging in prostate cancer |
| Q36469177 | Imaging localized prostate cancer: current approaches and new developments. |
| Q37546036 | Imaging modalities for prostate cancer |
| Q36125199 | Imaging prostate cancer: an update on positron emission tomography and magnetic resonance imaging |
| Q36460818 | Imaging techniques for prostate cancer: implications for focal therapy |
| Q38528397 | Implementation of Multi-parametric Prostate MRI in Clinical Practice. |
| Q53083265 | Incremental value of T2-weighted and diffusion-weighted MRI for prediction of biochemical recurrence after radical prostatectomy in clinically localized prostate cancer |
| Q38826330 | Learning Non-rigid Deformations for Robust, Constrained Point-based Registration in Image-Guided MR-TRUS Prostate Intervention |
| Q37270567 | MR imaging of the prostate in clinical practice |
| Q37018444 | Magnetic resonance-ultrasound fusion prostate biopsy in the diagnosis of prostate cancer |
| Q45258501 | Meta-analysis of Diffusion-Weighted Magnetic Resonance Imaging in Detecting Prostate Cancer |
| Q47795790 | Model selection for high b-value diffusion-weighted MRI of the prostate |
| Q27687291 | Molecular imaging for cancer diagnosis and surgery |
| Q42871630 | Molecular research in urology 2014: update on PET/MR imaging of the prostate |
| Q37406508 | Multidisciplinary functional MR imaging for prostate cancer |
| Q37937948 | Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. |
| Q38012217 | Multiparametric MRI and prostate cancer diagnosis and risk stratification |
| Q38212715 | Multiparametric MRI in prostate cancer management. |
| Q38658408 | Multiparametric magnetic resonance imaging for transition zone prostate cancer: essential findings, limitations, and future directions |
| Q26859699 | Multiparametric magnetic resonance imaging of the prostate: current concepts |
| Q37242030 | New horizons in prostate cancer imaging |
| Q37815634 | Pelvic Applications of Diffusion Magnetic Resonance Images |
| Q38589371 | Pitfalls in Interpreting mp-MRI of the Prostate: A Pictorial Review with Pathologic Correlation |
| Q46567823 | Practical aspects of prostate MRI: hardware and software considerations, protocols, and patient preparation |
| Q43497230 | Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results |
| Q37789105 | Prostate Cancer: Differentiation of Central Gland Cancer from Benign Prostatic Hyperplasia by Using Diffusion-weighted and Dynamic Contrast-enhanced MR Imaging |
| Q40078453 | Prostate cancer in magnetic resonance imaging: diagnostic utilities of spectroscopic sequences |
| Q43211072 | Prostate cancer: added value of subtraction dynamic imaging in 3T magnetic resonance imaging with a phased-array body coil. |
| Q51555022 | Prostate cancer: utility of fusion of T2-weighted and high b-value diffusion-weighted images for peripheral zone tumor detection and localization. |
| Q33746637 | Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation |
| Q40647574 | Prostate diffusion-weighted imaging at 3T: effect of intravenous gadobutrol administration. |
| Q58562204 | Prostate imaging features that indicate benign or malignant pathology on biopsy |
| Q43164602 | Reduced-FOV excitation decreases susceptibility artifact in diffusion-weighted MRI with endorectal coil for prostate cancer detection |
| Q54766079 | Revisiting the central gland anatomy via MRI: does the central gland extend below the level of verumontanum? |
| Q37218749 | Role of magnetic resonance methods in the evaluation of prostate cancer: an Indian perspective |
| Q40145539 | Stratification of the aggressiveness of prostate cancer using pre-biopsy multiparametric MRI (mpMRI). |
| Q37619516 | Technologies for localization and diagnosis of prostate cancer |
| Q37976257 | The emerging role of diffusion-weighted MRI in prostate cancer management |
| Q27006744 | The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel |
| Q26849794 | The role of magnetic resonance imaging in the diagnosis and management of prostate cancer |
| Q52944650 | The utility of CT and MRI in detecting male urethral recurrence after radical cystectomy |
| Q84577525 | Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation |
| Q53198801 | What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T? |
| Q83781522 | [Pelvic MRI at 3.0 Tesla] |
| Q82999281 | [The role of diffusion 3-Tesla MRI in detecting prostate cancer before needle biopsy: multiparametric study of 111 patients] |
Search more.